Neuralink, the brain tech startup founded by Elon Musk, has raised $650 million in its latest Series E funding round, pushing its valuation close to $9 billion.
Leading investors such as ARK Invest, Sequoia Capital, and Founders Fund participated in the financing. The company’s core product, the Link, is a coin sized neural implant that translates brain activity into digital commands, enabling users especially those with severe paralysis to control devices using only their thoughts.
Elon Musk’s Neuralink Powers Up with $650M
Recent clinical trials have demonstrated promising results in restoring communication and device control. The U.S. FDA has designated Neuralink’s speech and vision restoration devices as breakthrough technologies, expediting their regulatory approval process.
With this fresh capital, Neuralink plans to expand clinical testing across the U.S., Canada, and the UAE, continuing its mission to merge human cognition seamlessly with artificial intelligence.
